Literature DB >> 6119633

Tissue specificity of dopamine effects on brain ATPases.

M Antonelli de Gómez de Lima, G Rodríquez de Lores Arnaiz.   

Abstract

Dopamine inhibits Mg2+,Na+,K+- and Na+,K+-ATPase activities but does not modify Mg2+-ATPase activity of nerve ending membranes isolated from rat cerebral cortex. In the presence of the soluble fraction of brain, dopamine activates total, Na+,K+-, and Mg2+-ATPases. Dopamine stimulation of nerve ending membrane ATPases is achieved when soluble fractions of brain, kidney, or liver are used. On the other hand, dopamine effects are not observed on kidney or heart ATPase preparations. The results indicate tissue specificity of dopamine effect with respect to the enzyme source; there is no tissue specificity for the requirement of the soluble fraction to achieve stimulation of ATPases by dopamine.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6119633     DOI： 10.1007/bf00965028

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


  19 in total

1.  (Mg2+ + K+)-dependent inhibition of NaK-ATPase due to a contaminant in equine muscle ATP.

Authors:  P M Hudgins; G H Bond
Journal:  Biochem Biophys Res Commun       Date:  1977-08-08       Impact factor: 3.575

2.  The effects of ouabain and the activation of neural membrane ATPase by biogenic amines.

Authors:  J G Logan; D J O'Donovan
Journal:  J Neurochem       Date:  1976-07       Impact factor: 5.372

3.  Regulation of (Na+, K+) adenosinetriphosphatase of nerve ending membranes: action of norepinephrine and a soluble factor.

Authors:  G Rodriguez De Lores Arnaiz; M Mistrorigo De Pacheco
Journal:  Neurochem Res       Date:  1978-12       Impact factor: 3.996

4.  Activation of Na-K activated ATPase in rat brain by catecholamine.

Authors:  K Yoshimura
Journal:  J Biochem       Date:  1973-08       Impact factor: 3.387

5.  Purification and properties of a highly active ouabain-sensitive Na+, K+-dependent adenosinetriphosphatase from cardiac tissue.

Authors:  H Matsui; A Schwartz
Journal:  Biochim Biophys Acta       Date:  1966-11-15

6.  The action of EGTA on the catecholamines stimulation of rat brain Na-K-ATPase.

Authors:  T Godfraind; M C Koch; N Verbeke
Journal:  Biochem Pharmacol       Date:  1974-12-15       Impact factor: 5.858

7.  On the mechanism of supersensitivity to norepinephrine in the denervated cat spleen.

Authors:  S Brimijoin; S Pluchino; U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

8.  The effect of several neurotransmitter substances on nerve ending membrane ATPase.

Authors:  G R Lores Arnaiz; M A Gómez de Lima
Journal:  Acta Physiol Lat Am       Date:  1981

9.  Stimulation of cerebral cortical synaptosomal Na-K-ATPase by biogenic amines.

Authors:  S L Lee; J W Phillis
Journal:  Can J Physiol Pharmacol       Date:  1977-08       Impact factor: 2.273

10.  Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle.

Authors:  L C Cantley; L Josephson; R Warner; M Yanagisawa; C Lechene; G Guidotti
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157
View more
  6 in total

Review 1.  In search of synaptosomal Na+,K(+)-ATPase regulators.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

2.  Effect of tissue specificity of brain soluble fractions on Na+, K(+)-ATPase activity.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1990-03       Impact factor: 3.996

3.  Partial characterization of an endogenous factor which modulates the effect of catecholamines on synaptosomal Na+, K+-ATPase.

Authors:  G Rodríguez de Lores Arnaiz; M Antonelli de Gómez de Lima
Journal:  Neurochem Res       Date:  1986-07       Impact factor: 3.996

4.  An Unbiased Drug Screen for Seizure Suppressors in Duplication 15q Syndrome Reveals 5-HT1A and Dopamine Pathway Activation as Potential Therapies.

Authors:  Bidisha Roy; Jungsoo Han; Kevin A Hope; Tracy L Peters; Glen Palmer; Lawrence T Reiter
Journal:  Biol Psychiatry       Date:  2020-04-13       Impact factor: 13.382

5.  Different properties of two brain extracts separated in Sephadex G-50 that modify synaptosomal ATPase activities.

Authors:  G Rodríguez de Lores Arnaiz; M Antonelli de Gómez de Lima; E Girardi
Journal:  Neurochem Res       Date:  1988-03       Impact factor: 3.996

6.  The inhibitory activity of a brain extract on synaptosomal Na+, K+-ATPase is sensitive to carboxypeptidase A and to chelating agents.

Authors:  M Antonelli de Gómez de Lima; G Rodríquez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1988-03       Impact factor: 3.996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.